Marja-Liisa Sumelahti

Marja-Liisa Sumelahti

UNVERIFIED PROFILE

Are you Marja-Liisa Sumelahti?   Register this Author

Register author
Marja-Liisa Sumelahti

Marja-Liisa Sumelahti

Publications by authors named "Marja-Liisa Sumelahti"

Are you Marja-Liisa Sumelahti?   Register this Author

22Publications

223Reads

12Profile Views

Gene expression profiles of TNF-like cytokine 1A (TL1A) and its receptors death receptor 3 (DR3) and decoy receptor 3 (DcR3) in multiple sclerosis.

J Neuroimmunol 2019 Oct 14;335:577020. Epub 2019 Aug 14.

Neuroimmunology Unit, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland; Neuro Group, BioMediTech, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2019.577020DOI Listing
October 2019

Risk of cancer among Finnish multiple sclerosis patients.

Mult Scler Relat Disord 2019 Aug 5;35:221-227. Epub 2019 Aug 5.

Turku University Hospital, Division of Clinical Neurosciences and University of Turku, PL 52, Turku 20521, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2019.08.005DOI Listing
August 2019

Diffusion tensor imaging and disability progression in multiple sclerosis: A 4-year follow-up study.

Brain Behav 2019 01 26;9(1):e01194. Epub 2018 Dec 26.

Faculty of Medicine and Life Sciences, Tampere University, Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/brb3.1194DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346728PMC
January 2019

Medical students' experience of emotions and success in neurological studies - What do they tell us?

BMC Med Educ 2017 Apr 4;17(1):68. Epub 2017 Apr 4.

Faculty of Education, University of Oulu, B.O.X. 2000, 90014, Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12909-017-0905-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379665PMC
April 2017

Cost-utility of First-line Disease-modifying Treatments for Relapsing-Remitting Multiple Sclerosis.

Clin Ther 2017 Mar 14;39(3):537-557.e10. Epub 2017 Feb 14.

School of Medicine, University of Tampere, Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinthera.2017.01.028DOI Listing
March 2017

Injectable Disease Modifying Agents in Multiple Sclerosis: Pattern of Medication Use and Clinical Effectiveness.

Neurol Int 2016 Sep 30;8(3):6513. Epub 2016 Sep 30.

School of Medicine, University of Tampere , Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4081/ni.2016.6513DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066104PMC
September 2016

Increasing Incidence in Relapsing-Remitting MS and High Rates among Young Women in Finland: A Thirty-Year Follow-Up.

Mult Scler Int 2014 9;2014:186950. Epub 2014 Nov 9.

School of Medicine, University of Tampere, Arvo 312, 33014 Tampere, Finland ; Tampere University Hospital, P.O. Box 2000, 33521 Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2014/186950DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241579PMC
November 2014

[Woman, hormones and migraine].

Duodecim 2013 ;129(4):345-50

View Article

Download full-text PDF

Source
April 2013

Prescription patterns in preventive and abortive migraine medication.

Cephalalgia 2011 Dec 24;31(16):1659-63. Epub 2011 Nov 24.

University of Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102411427602DOI Listing
December 2011

Causes of death among patients with multiple sclerosis.

Mult Scler 2010 Dec 8;16(12):1437-42. Epub 2010 Sep 8.

Faculty of Medicine, University of Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458510379244DOI Listing
December 2010

Fine mapping of the multiple sclerosis susceptibility locus on 5p14-p12.

J Neuroimmunol 2005 Dec 19;170(1-2):122-33. Epub 2005 Sep 19.

Department of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2005.08.004DOI Listing
December 2005

Cancer incidence in multiple sclerosis: a 35-year follow-up.

Neuroepidemiology 2004 Sep-Oct;23(5):224-7

University of Tampere, School of Public Health, FI-33101 Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000079947DOI Listing
November 2004

Multiple sclerosis in western Finland: evidence for a founder effect.

Clin Neurol Neurosurg 2004 Jun;106(3):175-9

Department of Neurology, Helsinki University Central Hospital, University of Helsinki, Biomedicum Helsinki, Neuroscience Programme C522b, Haartmaninkatu 8, FIN-00290, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clineuro.2004.02.009DOI Listing
June 2004

HLA class II associated risk and protection against multiple sclerosis-a Finnish family study.

J Neuroimmunol 2002 Jan;122(1-2):140-5

Turku Immunology Centre and Department of Virology, University of Turku, Kiinamyllynkatu 13, FIN-20520, Turku, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0165-5728(01)00456-8DOI Listing
January 2002